Table 1.
Characteristics of Cervical Cancer Patients
| HPV Status | No. of Patients | Age, y, Median (Range) | Region of Saudi Arabia, n (%) | Gravidity, Median (Range) | Parity, Median (Range) | Histology, n (%) | Stage, n (%) | Associated Diseases, n (%) | Previous Screening, n (%) | Previous STD, n (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| HPV‐positive | 163 | 46 (29‐78) |
C: 74 (46) E: 43 (26) S: 16 (10) W: 15 (9) N: 15 (9) |
8 (0‐19) | 7 (0‐16) | AC: 31 (19) SCC: 132 (81) |
I: 42 (26) II: 78 (48) III: 36 (22) IV: 7 (4) |
Yes: 67 (41) No: 96 (59) |
Yes: 6 (4) No: 157 (96) |
Yes: 11 (7) No: 152 (93) |
| HPV‐negative | 50 | 44 (28‐74) |
C: 21 (42) E: 9 (18) S: 7 (14) W: 7 (14) N: 6 (12) |
6 (1‐13) | 6 (0‐12) |
AC: 9 (18) SCC: 41 (82) |
I: 17 (34) II: 21 (42) III: 9 (18) IV: 3 (6) |
Yes: 17 (34) No: 33 (66) |
Yes: 0 (0) No: 50 (100) |
Yes: 0 (0) No: 50 (100) |
| P a | .217 | .570 | .051 | .049 | .872 | .627 | .369 | .999 | .999 | |
| Unknown | 19 | 51 (30‐72) |
C: 13 (68) E: 6 (32) S: 0 (0) W: 0 (0) N: 0 (0) |
9 (5‐12) | 8 (5‐12) |
AC: 1 (5) SCC: 18 (95) |
I: 5 (26) II: 9 (48) III: 4 (21) IV: 1 (5) |
Yes: 10 (53) No: 9 (47) |
Yes: 0 (0) No: 19 (100) |
Yes: 0 (0) No: 19 (100) |
| Total | 232 | 46 (28‐78) |
C: 108 (47) E: 58 (25) S: 23 (10) W: 22 (9) N: 21 (9) |
8 (0‐19) | 7 (0‐16) |
AC: 41 (18) SCC: 191 (82) |
I: 64 (28) II: 108 (46) III: 49 (21) IV: 11 (5) |
Yes: 94 (41) No: 138 (59) |
Yes: 6 (3) No: 226 (97) |
Yes: 11 (5) No: 221 (95) |
AC, adenocarcinoma; C, central; E, eastern; N, northern; S, southern; SCC, squamous cell carcinoma; STD, sexually transmitted disease; W, western.
a
Significance level for the difference between HPV‐positive and HPV‐negative patients.